In vitro evaluation of enrofloxacin-loaded MLV liposomes

Drug Delivery

Volumn 14, Issue 1, 2007, Pages 47-53

  Sezer, Ali Demir ^a   Akbuǧa, Jülide ^a   Baş, Ahmet Levent ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Controlled Release; Drug Encapsulation; Enrofloxacin; Formulation; Liposome; MLV; Stability; Zeta Potential

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; DICETYL PHOSPHATE; DL ALPHA PHOSPHATIDYLCHOLINE DIPALMITOYL; DRUG CARRIER; ENROFLOXACIN; LIPOSOME; OCTADECYLAMINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; ELECTROPHORETIC MOBILITY; ENCAPSULATION; EVALUATION; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHYSICAL; CHOLESTEROL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; ELECTROCHEMISTRY; EXCIPIENTS; FLUOROQUINOLONES; KINETICS; LIPOSOMES; PARTICLE SIZE; SOLUBILITY;

EID: 33751084074     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540600640146     Document Type: Article

References (23)

1. Aoki, H., Sun, C., Fuji, K., and Miyajima, K. 1995. Disposition kinetics of liposomes modified with synthetic aminoglycolipids in rats. Int. J. Pharm. 15:183-191.
2. Baş, A. L., Elmas, M., Şimşek, A., et al. 2000. Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish shepherd dog neutrophils in vitro. Rev. Med. Vet. 151:415-420.
3. Baş, A. L., Şimşek, A., Çorlu, M., et al. 2002. Determination of intracellular concentration of free and two types of liposomes-encapsulated enrofloxacin in anatolian shepherd dog monocytes. J. Vet. Med. B. 49:1-5.
4. Bedrad, J., and Bryan, L. E. 1989. Interaction of the fluroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. Antimicrob. Agents Ch. 33:1379-1382.
5. Belsito, S., Bartucci, R., and Sportelli, L. 2005. Paclitaxel interaction with phospholipid bilayers: high-sensitivity differential scanning calorimetric study. Thermochim. Acta 427:175-180.
6. Cabanes, A., Reig, F., Anton, J. M. G., and Arboix, M. 1995. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits. Am. J. Vet. Res. 56:1498-1501.
7. Castelli, F., Caruso, S., and Giuffrida, N. 1999. Different effects of two structurally similar carotenoids, lutein and b-carotene, on the thermotropic behaviour of phosphatidylcholine liposomes. Calorimetric evidence of their hindered transport through biomembranes. Thermochim. Acta 327:125-131.
8. Castelli, F., Raudino, A., and Fresta, M. 2005. A mechanistic study of the permeation kinetics through biomembrane models: Gemcitabine-phospholipid bilayer interaction. J. Colloid. Interf. Sci. 285:110-117.
9. Grabielle-Madelmont, C., Lesieur, S., and Ollivon, M. 2003. Characterization of loaded liposomes by size exclusion chromatography. J. Biochem. Biophys. Meth. 56:189-217.
10. Kulkarni, S. B., Betageri, G. V., Singh, M. 1995. Factor affecting microencapsulation of drug in liposomes. J. Microencapsul. 12:229-246.
11. Lang, J. K., and Vigo-Pelfrey, C. 1993. Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol. Chem. Phys. Lipids. 64:19-29.
12. Lian, T., and Ho, R. J. Y. 2001. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90:667-680.
13. Lizondo, M., Pons, M., Gallardo, M., and Estelrich, J. 1997. Physicochemical properties of enrofloxacin. J. Pharm. Biomed. Anal. 15:1845-1849.
14. 1H-NMR study. Biochim. Biophys. Acta 1374:9-20.
15. Montero, M. T., Carrera, I., and Hernandez-Borrell, J. 1994. Encapsulation of a quinolone in liposomes. Location and effect on lipid bilayers. J. Microencapsul. 11:423-430.
16. Mohammeda, A. R., Westonb, N., Coombesa, A. G. A., et al. 2004. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int. J. Pharm. 285:23-34.
17. New, R. R. C. 1995. Influence of liposome characteristics on their properties and fate. In Liposome as Tools in Basic Research and Industry, ed. Philippot, J. R. and Schuber, F., 4-20. Florida: CRC Press.
18. Plessis, J., Ramachandran, C., Weiner, N., and Müller, D.G. 1996. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int. J. Pharm. 127:273-278.
19. Pons, M., Foradada, M., and Esteirich, J. 1993. Liposomes obtained by the ethanol injection method. Int. J. Pharm. 95:51-56.
20. Puglisi, G., Fresta, M., Mazzone, G., et al. 1995. Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity. Int. J. Pharm. 118:65-76.
21. Sezer, A. D., Baş, A. L., and Akbuǧa, J. 2002. Effect of formulation variables on the characteristics of enrofloxacin liposomes, 62nd International World Congress of FIP, 31 August-5 September, Nice, France, p. 28.
22. Sezer, A. D., Baş, A. L., and Akbuǧa, J. 2004. Encapsulation of enrofloxacin in liposomes I: in vito characterization of LUV. J. Liposome Res. 14 (1-2):77-86.
23. Vays, S. P., Goswami, S. K., and Singh, R. 1995. Liposomes based nasal delivery system of nifedipine: development and characterization. Int. J. Pharm. 118:23-30.